Prelude Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$490K Buy
2025
Q2
Sell
2025
Q1
$1.27M Sell
2024
Q4
$2.16M Buy
2024
Q2
Hold
2024
Q1
Hold
2020
Q3
Hold
2020
Q2
Hold
2019
Q3
Sell
2019
Q2
$194K Sell
2019
Q1
$556K Buy
2018
Q4
$237K Buy
2018
Q3
$29K Sell
2018
Q2
$755K Buy